Total
USD $0.00
 
Bangladesh

Company Overview of Square Pharmaceuticals Ltd

An EMIS Company Report EMIS is an ISI Emerging Markets Group Company Company Description

Square Pharmaceuticals Limited operates as the flagship company of Square Group. The company pioneered exports of medicines from Bangladesh in 1987 and has been exporting antibiotics and other pharmaceutical products. It was converted into a public limited company in 1991. It was established in 1985 and is headquartered in Dhaka.

Need a report on this company? USD 29.95 Industry: Pharmaceutical and Medicine Manufacturing Available in: English Format: PDF Download Most recent financial data: 2017 Buy full report

Report contents

On purchasing the report for this company you will have access to a PDF containg the most recent data for Square Pharmaceuticals Ltd from the EMIS database.

To give you a clear idea of the information provided, you can download a sample report for a different company below.

Download a sample report
NAICS Industry Classification
Main Activities: Pharmaceutical and Medicine Manufacturing
Contact Information

Legal Address
Square Centre,48 Mohakhali Commerical Area
Dhaka; Dhaka; Postal Code: 1212

Tel: +880-02883,+880-02883
Fax: +880-02882

Email:
@squaregroup.com

Website:
http://www.squarepharma.com.bd

Basic Information
Total Employees:
7,390 (2017)
Outstanding Shares:
Provided in the purchased report
Registered Capital:
Provided in the purchased report
Financial Auditors:
Provided in the purchased report
Incorporation Date:
1985
Key Executives
Provided in the purchased report
Chief Financial Officer
Provided in the purchased report
Chairman of the Board
Provided in the purchased report
Vice Chairman
Provided in the purchased report
Director
Provided in the purchased report
Director
More
Ownership Details
Sponsors And Directors
36.34%
General Public
34.09%
Foreign Investors
19.75%
Financial &Amp; Other Institutions
9.82%

Report contents

On purchasing the report for this company you will have access to a PDF containg the most recent data for Square Pharmaceuticals Ltd from the EMIS database.

To give you a clear idea of the information provided, you can download a sample report for a different company below.

Download a sample report
Key Financial Highlights
Annual growth percentages* for latest two years in USD terms. Absolute financial data is included in the purchased report.
Net sales revenue
6.06%
Total operating revenue
3.2%
Operating profit (EBIT)
-5.49%
EBITDA
Net Profit (Loss) for the Period
7.09%
Total assets
11.29%
Total equity
14.35%
Operating Profit Margin (ROS)
-4.05%
Net Profit Margin
0.27%
Return on Equity (ROE)
-0.92%
Debt to Equity Ratio
Quick Ratio
40.96%
Cash Ratio
14.6%
* Growth figures are affected by the currency rate changes.
Company News (Not included in report)
Enterprise ACCESS

If you need regular and ongoing access to company information, you should consider a subscription to the full EMIS service.

EMIS company profiles are part of a larger information service where that combines company, industry and country data and analysis for over 125 emerging markets on a unique information platform.

Request a demonstration of the EMIS service

To view more information, Request a demonstration of the EMIS service